Company Filing History:
1 out of 377 
3 out of 832,880 Years Active: 2001-2004
Title: Marc Abitbol: Pioneering Innovations in Neurodegenerative Disease Treatment
Introduction
Marc Abitbol, an accomplished inventor based in Paris, France, has made significant contributions to the fields of biotechnology and medicine. With a total of four patents to his name, his work focuses on innovative solutions aimed at tackling critical health challenges, particularly neurodegenerative diseases.
Latest Patents
Among his notable patents is one for "Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)." This invention details recombinant adenoviruses that comprise a heterologous DNA sequence coding for basic fibroblast growth factors (bFGF), along with the preparation and uses for treating and preventing neurodegenerative diseases. Additionally, he has patented a method for "Intraocular transplantation of encapsulated cells," which involves reducing ocular diseases by implanting a composition with encapsulated cells in the eye. These cells produce polypeptides that have neurotrophic and anti-angiogenic activity. The encapsulation technique is designed to prevent the entry of host immune cells while allowing the polypeptides to be released from the microcapsule.
Career Highlights
Marc Abitbol has worked with prominent companies in the pharmaceutical sector, including Aventis Pharma S.A. His role in these organizations has likely provided him with the necessary tools and environment to nurture his inventive ideas, leading to notable advancements in therapeutic treatments.
Collaborations
Throughout his career, Marc has collaborated with distinguished colleagues, including Yves Uteza and Maurice Menasche. These partnerships have contributed to the pooling of expertise and innovation, further enhancing the impact of his inventions in the medical field.
Conclusion
Marc Abitbol's contributions through his patents and collaborative efforts reflect a deep commitment to advancing healthcare solutions. His inventions hold promise not only for their therapeutic applications but also for the future of medicine in treating complex diseases.